Form 4: CorMedix Executive Vice President Sells Shares to Cover Tax Obligations

Elizabeth Hurlburt, Executive Vice President of CorMedix Inc., sold 5,790 shares of common stock on January 10, 2025, to cover tax obligations.

Summary

• Elizabeth Hurlburt, an Executive Vice President at CorMedix Inc., sold 5,790 shares of the company's common stock on January 10, 2025.
• The sale was executed at a price of $11.19 per share.
• This transaction was conducted to cover tax obligations related to the vesting of restricted stock units.
• Following the transaction, Ms. Hurlburt directly owns 115,728 shares of CorMedix common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction by an executive to cover tax obligations. It is neither positive nor negative for the company's outlook.

Industry Context

This is a routine transaction for executives to manage their personal finances and tax obligations related to stock-based compensation. It is common for executives to sell shares after vesting.

Comparison to Industry Standards

• Executive stock sales are a common occurrence in publicly traded companies, particularly after stock options or restricted stock units vest.
• The sale of 5,790 shares by an EVP is not unusual and is within the typical range of such transactions.
• Similar transactions are regularly reported by executives at comparable companies in the biotech and pharmaceutical sectors.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale by an executive.
• There is no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

CorMedix, CRMD, stock sale, insider trading, executive, Elizabeth Hurlburt, Form 4, SEC